Wellington Management Group LLP Reduces Holdings in Aemetis, Inc. (NASDAQ:AMTX)

Wellington Management Group LLP decreased its position in shares of Aemetis, Inc. (NASDAQ:AMTX) by 66.2% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 26,012 shares of the specialty chemicals company’s stock after selling 51,044 shares during the period. Wellington Management Group LLP’s holdings in Aemetis were worth $70,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in AMTX. ProShare Advisors LLC purchased a new stake in Aemetis during the 4th quarter worth $27,000. Voya Investment Management LLC purchased a new stake in Aemetis during the 4th quarter worth $28,000. Tower Research Capital LLC TRC increased its stake in Aemetis by 128.8% during the 4th quarter. Tower Research Capital LLC TRC now owns 10,407 shares of the specialty chemicals company’s stock worth $28,000 after buying an additional 5,859 shares during the period. Intech Investment Management LLC purchased a new stake in Aemetis during the 4th quarter worth $46,000. Finally, SG Americas Securities LLC purchased a new stake in Aemetis during the 4th quarter worth $87,000. Hedge funds and other institutional investors own 27.02% of the company’s stock.

Aemetis Price Performance

Shares of AMTX stock opened at $1.95 on Monday. The firm has a market cap of $107.97 million, a P/E ratio of -0.86 and a beta of 1.48. Aemetis, Inc. has a 1-year low of $1.22 and a 1-year high of $4.73. The firm has a fifty day moving average of $1.55 and a two-hundred day moving average of $2.15.

Aemetis (NASDAQ:AMTX) last announced its quarterly earnings data on Thursday, May 8th. The specialty chemicals company reported ($0.47) earnings per share for the quarter, missing the consensus estimate of ($0.39) by ($0.08). The business had revenue of $42.89 million for the quarter, compared to the consensus estimate of $59.35 million. During the same period in the prior year, the company posted ($0.58) earnings per share. On average, sell-side analysts expect that Aemetis, Inc. will post -2.07 EPS for the current year.

Wall Street Analyst Weigh In

AMTX has been the topic of several analyst reports. HC Wainwright reaffirmed a “buy” rating and set a $28.00 price target on shares of Aemetis in a research note on Friday, March 14th. Ascendiant Capital Markets raised their price objective on shares of Aemetis from $19.00 to $20.00 and gave the stock a “buy” rating in a report on Friday. Finally, UBS Group decreased their price objective on shares of Aemetis from $2.50 to $2.20 and set a “buy” rating for the company in a report on Friday, May 9th. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating and three have given a buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $13.43.

Aemetis Company Profile

Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.